StockData
Integra LifeSciences Holdings Corp logo

Integra LifeSciences Holdings Corp (IART) stock

IARTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 23, 2026Score 9/306% below fair value
$13.86+0.31 (+2.29%)

Close on Nov 18, 2026Market cap $1.08BP/E 81.5Yield –

Integra LifeSciences revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Integra LifeSciences's revenue for the twelve months ending Sep 30, 2026 was $1.66B, up 0.8% year over year. For fiscal 2025 it was $1.64B, up 1.5% from the year before. Over ten years it grew 6.4% a year on average. The highest annual figure on record is $1.64B in fiscal 2025.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$1.64B+1.5%
FY2024Dec 31, 2024$1.61B+4.5%
FY2023Dec 31, 2023$1.54B-1.0%
FY2022Dec 31, 2022$1.56B+1.0%
FY2021Dec 31, 2021$1.54B+12.4%
FY2020Dec 31, 2020$1.37B-9.6%
FY2019Dec 31, 2019$1.52B+3.1%
FY2018Dec 31, 2018$1.47B+23.9%
FY2017Dec 31, 2017$1.19B+19.8%
FY2016Dec 31, 2016$992.08M+12.4%
FY2015Dec 31, 2015$882.73M+10.8%
FY2014Dec 31, 2014$796.72M+14.3%
FY2013Dec 31, 2013$696.83M-16.1%
FY2012Dec 31, 2012$830.87M+6.5%
FY2011Dec 31, 2011$780.08M+6.6%
FY2010Dec 31, 2010$732.07M+7.3%
FY2009Dec 31, 2009$682.49M+4.3%
FY2008Dec 31, 2008$654.60M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$411.18M+2.3%
Q2 FY2026Jun 30, 2026$418.76M+0.8%
Q1 FY2026Mar 31, 2026$391.92M+2.4%
Q4 FY2025Dec 31, 2025$434.93M-1.7%
Q3 FY2025Sep 30, 2025$402.06M+5.6%
Q2 FY2025Jun 30, 2025$415.61M-0.6%
Q1 FY2025Mar 31, 2025$382.65M+3.7%
Q4 FY2024Dec 31, 2024$442.65M+11.5%
Q3 FY2024Sep 30, 2024$380.83M-0.4%
Q2 FY2024Jun 30, 2024$418.18M+9.7%
Q1 FY2024Mar 31, 2024$368.87M-3.1%
Q4 FY2023Dec 31, 2023$397.04M-0.2%
Q3 FY2023Sep 30, 2023$382.42M-0.7%
Q2 FY2023Jun 30, 2023$381.27M-4.2%
Q1 FY2023Mar 31, 2023$380.85M+1.1%
Q4 FY2022Dec 31, 2022$398.02M-1.8%
Q3 FY2022Sep 30, 2022$385.19M-0.4%
Q2 FY2022Jun 30, 2022$397.82M+2.0%
Q1 FY2022Mar 31, 2022$376.64M+4.6%
Q4 FY2021Dec 31, 2021$405.52M+4.3%
Q3 FY2021Sep 30, 2021$386.86M+4.5%
Q2 FY2021Jun 30, 2021$389.99M+50.8%
Q1 FY2021Mar 31, 2021$360.07M+1.6%
Q4 FY2020Dec 31, 2020$388.65M-1.6%
Q3 FY2020Sep 30, 2020$370.23M-2.3%
Q2 FY2020Jun 30, 2020$258.67M-32.6%
Q1 FY2020Mar 31, 2020$354.32M-1.5%
Q4 FY2019Dec 31, 2019$395.13M+3.1%
Q3 FY2019Sep 30, 2019$379.10M+3.6%
Q2 FY2019Jun 30, 2019$383.65M+4.8%
Q1 FY2019Mar 31, 2019$359.69M+0.7%
Q4 FY2018Dec 31, 2018$383.32M+4.0%
Q3 FY2018Sep 30, 2018$365.85M+31.2%
Q2 FY2018Jun 30, 2018$366.19M+29.8%
Q1 FY2018Mar 31, 2018$357.08M+38.1%
Q4 FY2017Dec 31, 2017$368.60M+44.2%
Q3 FY2017Sep 30, 2017$278.83M–
Q2 FY2017Jun 30, 2017$282.16M–
Q1 FY2017Mar 31, 2017$258.64M–
Q4 FY2016Dec 31, 2016$255.66M–

More Integra LifeSciences figures

See a number that looks wrong?